P084 Musashi-2 Expression Is an Prognostic Factor for Postoperative Survival in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.10.097
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Is DNA Ploidy Pattern a Prognostic Factor for Postoperative Adjuvant Chemotherapy for Non-Small Cell Lung Cancer?

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2001English

Prognostic Significance of Pigment Epithelium-Derived Factor Expression in Patients With Non-Small-Cell-Lung Cancer

Advances in Lung Cancer
2016English

Prognostic Significance of CD31 Expression in Patients With Non-Small-Cell-Lung Cancer

Advances in Lung Cancer
2016English

Pre‑treatment Hemoglobin Levels Are an Independent Prognostic Factor in Patients With Non‑small Cell Lung Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2018English

BAP1 Is a Good Prognostic Factor in Advanced Non-Small Cell Lung Cancer

Clinical and Investigative Medicine
Medicine
2012English

P3.15-15 ALI Could Be a One of Prognostic Survival Factor for Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Indoleamine 2,3-Dioxygenase as a Prognostic Factor in Patients With Non-Small Cell Lung Cancer

Journal of Clinical & Cellular Immunology
2014English

Peripheral Immune Cell Gene Expression Predicts Survival of Patients With Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2012English

Age Is a Prognostic Factor Affecting Survival in Lung Cancer Patients

Oncology Letters
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy